SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sigyn Therapeutics, Inc.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $48.16K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.9700 (−98.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2025
Valuation
- Market cap
- $48.16K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$3.22M
- EPS, diluted
- -$2.01
- Book value per share
- -$3.69
- Diluted shares
- 2M
Twelve years at a glance
Fiscal years 2013 to 2024 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$1.88M
Net income
-$3.22M
EPS, diluted
-$2.01
Free cash flow
–
Reported periodTrailing twelve months